Gram Positive Bacteria.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
INVITED SPEAKERS (INV) Presentation: Monday, September 28, 2015 from 10:30 – 11:00 in Room Congress Saal
INVITED SPEAKERS (INV) Presentation: Monday, September 28, 2015 from 10:30 – 11:00 in room Congress Saal. INV01 Redefining Virulence: Bacterial Gene Expression during INV03 Human Infection Breath-taking viral zoonosis: Lessons from influenza viruses H. L. T. Mobley T. Wolff University of Michigan Medical School, Department of Robert Koch-Institut, Division 17, Influenza viruses and other Microbiology and Immunology, Ann Arbor, United States Respiratory Viruses, Berlin, Germany Investigators identifying virulence genes at first did so by The World Health Organization recently expressed concerns about examining transposon mutants or individual gene mutations. an unprecedented diversity and geographical distribution of Mutants of bacterial pathogens were then assessed in animals, influenza viruses currently circulating in animal reservoirs. This whose symptoms mimicked human disease. Later, genome-wide includes an increase in the detection of animal influenza viruses screens (STM, IVET, IVIAT) were developed whereby genes and that co-circulate and exchange viral genes giving rise to novel virus proteins that influence virulence could be identified. These efforts strains. As the avian and porcine host reservoirs have in the past led to our conventional view of microbial virulence, with its focus contributed essentially to the genesis of human pandemic influenza on adhesins, iron acquisition, toxins, secretion, and motility, as viruses causing waves of severe respiratory disease on a global well as on those bacteria with genes such as on horizontally scale, this is a notable situation. transferred pathogenicity-associated islands that are not found in Zoonotic transmissions of avian influenza viruses belonging to the commensal strains. Now, however, we also must consider what H5N1 or H7N9 subtypes have been well documented in recent metabolic pathways are in play when microbial pathogens infect years. -
| Hao Wanatha Maria Del Contatta Datum
|HAO WANATHA MARIAUS009844679B2 DEL CONTATTA DATUM (12 ) United States Patent ( 10 ) Patent No. : US 9 ,844 , 679 B2 Nayfach - Battilana ( 45 ) Date of Patent : * Dec . 19 , 2017 (54 ) NANOPARTICLE - SIZED MAGNETIC (56 ) References Cited ABSORPTION ENHANCERS HAVING THREE - DIMENSIONAL GEOMETRIES U . S . PATENT DOCUMENTS ADAPTED FOR IMPROVED DIAGNOSTICS 4 , 106 ,488 A 8 / 1978 Gordon AND HYPERTHERMIC TREATMENT 4 ,303 ,636 A 12/ 1981 Gordon ( 71 ) Applicant: Qteris, Inc. , San Rafael, CA (US ) ( Continued ) ( 72 ) Inventor : Joseph N . Nayfach - Battilana , San FOREIGN PATENT DOCUMENTS Rafael , CA (US ) EP 0040512 B1 11 / 1981 EP 0136530 A16 /1988 (73 ) Assignee : Qteris, Inc. , San Rafael , CA (US ) (Continued ) ( * ) Notice : Subject to any disclaimer , the term of this patent is extended or adjusted under 35 OTHER PUBLICATIONS U . S . C . 154 ( b ) by 903 days. “ Krishna et al ., Unusual size -dependent magnetization in near This patent is subject to a terminal dis hemispherical Co nanomagnets on SiO . sub . 2 from fast pulsed laser claimer . processing” , J . Appl. Phys. 103 , 073902 (2008 ) (“ Krishna ” ) .* (Continued ) ( 21 ) Appl . No .: 14 /044 , 251 Primary Examiner — Joseph Stoklosa (22 ) Filed : Oct. 2 , 2013 Assistant Examiner — Adam Avigan (74 ) Attorney , Agent, or Firm — Marek Alboszta (65 ) Prior Publication Data US 2014 /0172049 A1 Jun . 19 , 2014 (57 ) ABSTRACT Nanoparticle- sized magnetic absorption enhancers (MAES ) Related U . S . Application Data exhibiting a controlled response to a magnetic field , includ ing a controlled mechanical response and an inductive (62 ) Division of application No . 12 /925 ,904 , filed on Nov. thermal response . The MAEs have a magnetic material that 1 , 2010 , now Pat . -